AQR CAPITAL MANAGEMENT LLC

Position in OMER — Omeros Corp

CIK 1167557 Greenwich, CT

Position in OMER

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$318,678

-$73,676 QoQ

Shares Held

30,178

+32.1% QoQ

Ownership

0.042%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

AQR CAPITAL MANAGEMENT LLC holds $4,606,751,734 across 214 Biotechnology names. OMER ranks #178 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	1,231,008	$951,126,014
2	EXEL	Exelixis, Inc.	13,095,741	$561,676,326
3	INCY	Incyte Corp	5,807,930	$546,642,368
4	BMRN	Biomarin Pharmaceutical Inc	7,676,541	$433,647,798
5	ALNY	Alnylam Pharmaceuticals, Inc.	913,104	$302,118,715
6	JAZZ	Jazz Pharmaceuticals plc	1,338,458	$253,035,481
7	RPRX	Royalty Pharma plc	3,782,038	$181,424,357
8	ROIV	Roivant Sciences Ltd.	5,946,858	$164,727,963

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$318,678	30,178	+32.1%	Shares	Defined	2026-05-15
2025-12-31	$392,354	22,838	+7.2%	Shares	Other	2026-02-17
2025-09-30	$87,353	21,306	+53.7%	Shares	Defined	2025-11-14
2025-06-30	$41,586	13,862	-60.1%	Shares	Defined	2025-08-14
2025-03-31	$285,233	34,700	-11.5%	Shares	Other	2025-05-15
2024-12-31	$387,215	39,192	+63.4%	Shares	Other	2025-02-14
2024-09-30	$95,192	23,978	-7.1%	Shares	Defined	2024-11-14
2024-06-30	$104,747	25,800	-27.5%	Shares	Other	2024-08-14
2023-09-30	$103,849	35,565	—	Shares	Defined	2023-11-14
No filing history on record for this holder in this stock.